Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Development of masked therapeutic antibodies to limit off-target effects

Development of masked therapeutic antibodies to limit off-target effects

US Patent 11311622 · Granted Apr 26, 2022

Estimated economic value: $3,059,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterodimeric antibodies that bind CD3 and CLDN62025
Activatable masked anti-CTLA4 binding proteins2025
Anti-CD6 antibody-growth factor complex for treating autoimmune diseases2025
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2024
Multi-specific ligand binders2024
CTLA4-binding protein peptide-linker masks2024
CTLA4-binding protein peptide-linker masks2024
Mechanically interlocking complexes2024
Heterodimeric antibodies that bind CD3 and CLDN62023
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2023
Tumor-selective CTLA-4 antagonists2022
Tumor-selective CTLA-4 antagonists2022